Literature DB >> 21562909

In vitro screening for antihyperlipidemic activities in foodstuffs by evaluating lipoprotein profiles secreted from human hepatoma cells.

Jyunichiro Takahashi, Gen Toshima, Yukie Matsumoto, Fumiko Kimura, Takanobu Kiuchi, Kentaro Hamada, Keishi Hata.   

Abstract

We screened the antihyperlipidemic effects of seven edible plants by evaluation of the triglyceride (TG) and cholesterol profiles secreted from HepG2 cells. We found that the water- and ethanol-extracts of Brasenia schreberi at 100 μg/ml exhibited strong inhibitory activities against TG and cholesterol secretions from HepG2 cells stimulated with sodium oleate. Real-time RT-PCR analysis demonstrated that ethanol extract of B. schreberi (BSET) attenuated the expression of the sterol regulatory element binding protein-1c and -2, fatty acid synthase and HMG CoA synthase-1 genes, which are involved in lipid synthesis in hepatocyte/hepatoma cells. Furthermore, we studied the action of BSET on adipose tissue accumulation and serum parameters in mice fed a high-fat diet (HFD). BSET suppressed mesenteric and epididymal adipose tissue accumulation and normalized serum TG and glucose, but not cholesterol levels in HFD-fed mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562909     DOI: 10.1007/s11418-011-0542-x

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  13 in total

1.  Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean beta-conglycinin.

Authors:  Mitsutaka Kohno; Motohiko Hirotsuka; Makoto Kito; Yuji Matsuzawa
Journal:  J Atheroscler Thromb       Date:  2006-10       Impact factor: 4.928

Review 2.  Structure of apolipoprotein B-100 in low density lipoproteins.

Authors:  J P Segrest; M K Jones; H De Loof; N Dashti
Journal:  J Lipid Res       Date:  2001-09       Impact factor: 5.922

3.  Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.

Authors:  Mitsuyo Okazaki; Shinichi Usui; Masato Ishigami; Naohiko Sakai; Tadashi Nakamura; Yuji Matsuzawa; Shizuya Yamashita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-06       Impact factor: 8.311

4.  Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of very low density lipoprotein in HepG2 cells.

Authors:  S H Wong; E A Fisher; J B Marsh
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

5.  CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans.

Authors:  Charles E Chandler; Donald E Wilder; Judith L Pettini; Yvette E Savoy; Stephen F Petras; George Chang; John Vincent; H James Harwood
Journal:  J Lipid Res       Date:  2003-07-01       Impact factor: 5.922

6.  Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome.

Authors:  Michiyo Deushi; Mitsunori Nomura; Akio Kawakami; Mihoko Haraguchi; Mizuho Ito; Mitsuyo Okazaki; Hideto Ishii; Masayuki Yoshida
Journal:  FEBS Lett       Date:  2007-11-20       Impact factor: 4.124

Review 7.  Plasma lipoproteins: apolipoprotein structure and function.

Authors:  R W Mahley; T L Innerarity; S C Rall; K H Weisgraber
Journal:  J Lipid Res       Date:  1984-12-01       Impact factor: 5.922

8.  Bile acid-binding activity of young persimmon (Diospyros kaki) fruit and its hypolipidemic effect in mice.

Authors:  Kenji Matsumoto; Shin-ichiro Yokoyama; Nobuki Gato
Journal:  Phytother Res       Date:  2010-02       Impact factor: 5.878

9.  HPLC analysis of lipoproteins in culture medium of hepatoma cells: an in vitro system for screening antihyperlipidemic drugs.

Authors:  Mizuho Itoh; Yukie Abe; Yuka Iwama; Fumiko Kimura; Mayumi Satoh; Mayumi Shoji; Junichiro Takahashi; Gen Toshima; Hiroki Sasaki; Kazuyuki Hiwatashi; Keishi Hata
Journal:  Biotechnol Lett       Date:  2009-03-29       Impact factor: 2.461

Review 10.  Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease.

Authors:  Sven-Olof Olofsson; Olov Wiklund; Jan Borén
Journal:  Vasc Health Risk Manag       Date:  2007
View more
  4 in total

1.  Inhibition of the DNA polymerase and RNase H activities of HIV-1 reverse transcriptase and HIV-1 replication by Brasenia schreberi (Junsai) and Petasites japonicus (Fuki) components.

Authors:  Tetsuro Hisayoshi; Mayu Shinomura; Kanta Yokokawa; Ikumi Kuze; Atsushi Konishi; Kumi Kawaji; Eiichi N Kodama; Keishi Hata; Saori Takahashi; Satoru Nirasawa; Shohei Sakuda; Kiyoshi Yasukawa
Journal:  J Nat Med       Date:  2015-02-08       Impact factor: 2.343

2.  Advantages of assessing lipoprotein profiles in hepatic cell differentiation.

Authors:  Junichiro Takahashi; Fumiko Kimura; Mizuho Miura; Yuka Iwama; Gen Toshima; Keishi Hata
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

3.  An in vitro assay system for antihyperlipidemic agents by evaluating lipoprotein profiles from human intestinal epithelium-like cells.

Authors:  Junichiro Takahashi; Kikumi Ogihara; Yuko Naya; Fumiko Kimura; Mizuho Itoh; Yuka Iwama; Yukie Matsumoto; Gen Toshima; Keishi Hata
Journal:  3 Biotech       Date:  2012-09-05       Impact factor: 2.406

4.  Polysaccharide gel coating of the leaves of Brasenia schreberi lowers plasma cholesterol in hamsters.

Authors:  Hyunsook Kim; Qian Wang; Charles F Shoemaker; Fang Zhong; Glenn E Bartley; Wallace H Yokoyama
Journal:  J Tradit Complement Med       Date:  2014-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.